耳鳴・感音難聴に対するメチルコバラミン (メチコバール(R)) 投与経験

DOI
  • 木村 守
    Department of Otorhinolaryngology, Okayama University, School of Medicine
  • 佐藤 嘉余子
    Department of Otorhinolaryngology, Okayama University, School of Medicine
  • 米田 智明
    Department of Otorhinolaryngology, Okayama University, School of Medicine
  • 木口 真樹
    Department of Otorhinolaryngology, Okayama University, School of Medicine
  • 頼実 哲
    Department of Otorhinolaryngology, Okayama University, School of Medicine
  • 西岡 絵理子
    Department of Otorhinolaryngology, Okayama University, School of Medicine
  • 松原 浄
    Department of Otorhinolaryngology, Okayama University, School of Medicine
  • 増田 游
    Department of Otorhinolaryngology, Okayama University, School of Medicine

書誌事項

タイトル別名
  • Clinical evaluation of methyl B<SUB>12</SUB> for tinnitus and hearing loss
  • Evaluationby “ Standard tinnitus test 1984 ”
  • 標準耳鳴検査による評価
公開日
1987
DOI
  • 10.11334/jibi1954.33.5_867
公開者
JIBI TO RINSHO KAI

この論文をさがす

説明

Clinical effects of metyl B12 were evaluated in 30 patients with tinnitus at the ENT clinic of Okayama University Hospital. All patients suffered from subjective tinnitus. In 27 cases the tinnitus was accompanied by sensorineural hearing loss, 3 cases were without hearing loss. Methyl B12 was administrated 1,500 μg/day for 8 weeks to all patients. The patients were tested by “standard tinnitus test 1984” and pure tone audiometry, before and after 8 weeks admdinistration. 18 of 30 cases were improved. General efficacy rate was 60%. No side effects were noted in any case.

収録刊行物

キーワード

詳細情報 詳細情報について

  • CRID
    1390282680476520064
  • NII論文ID
    130004403307
  • DOI
    10.11334/jibi1954.33.5_867
  • ISSN
    04477227
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ